As of March 2025, the U.S. stock market has been experiencing a mixed performance, with major indices like the S&P 500 and Nasdaq posting their third straight weekly declines despite a recent rebound following positive comments from Federal Reserve Chair Jerome Powell. Amidst this backdrop of volatility and economic uncertainty, growth companies with high insider ownership can offer unique insights into potential investment opportunities, as insiders often have a deeper understanding of their company's prospects and are more likely to invest in businesses they believe will succeed.
Name | Insider Ownership | Earnings Growth |
Atour Lifestyle Holdings (NasdaqGS:ATAT) | 26% | 25.6% |
Duolingo (NasdaqGS:DUOL) | 14.4% | 37% |
Hims & Hers Health (NYSE:HIMS) | 13.2% | 21.9% |
Corcept Therapeutics (NasdaqCM:CORT) | 11.7% | 36.7% |
Kingstone Companies (NasdaqCM:KINS) | 17.9% | 24.2% |
Astera Labs (NasdaqGS:ALAB) | 15.9% | 61.1% |
BBB Foods (NYSE:TBBB) | 16.5% | 41.1% |
Clene (NasdaqCM:CLNN) | 20.7% | 59.1% |
Upstart Holdings (NasdaqGS:UPST) | 12.7% | 100.1% |
Credit Acceptance (NasdaqGS:CACC) | 14.4% | 33.6% |
Click here to see the full list of 205 stocks from our Fast Growing US Companies With High Insider Ownership screener.
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Astrana Health, Inc. is a physician-centric technology-powered healthcare management company providing medical care services in the United States, with a market cap of approximately $1.41 billion.
Operations: Astrana Health generates revenue through its segments: Care Delivery ($136.67 million), Care Partners ($1.95 billion), and Care Enablement ($155.45 million).
Insider Ownership: 13.2%
Astrana Health's revenue is forecast to grow at 18% annually, outpacing the US market. Despite a recent net loss in Q4 2024, annual earnings are expected to increase significantly over the next three years. The company trades below its estimated fair value and anticipates revenue up to US$2.7 billion in 2025. Recent financial activities include a substantial credit agreement for acquisitions and a share repurchase program, although insider trading data is unavailable.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Afya Limited is a medical education group operating in Brazil with a market cap of approximately $1.55 billion.
Operations: The company's revenue is primarily derived from its Undergrad segment, which generated R$2.78 billion, and its Continuing Education segment, contributing R$164.55 million.
Insider Ownership: 15.3%
Afya is forecast to experience robust revenue growth at 9.6% annually, surpassing the US market average. Its earnings are expected to increase by 18.87% per year, outpacing the broader market's growth rate of 13.9%. The stock trades at a significant discount to its estimated fair value and shows high return on equity projections (20.2%). No recent insider trading activity is reported, and the company concluded its buyback plan in December 2024.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: loanDepot, Inc. operates in the United States by originating, financing, selling, and servicing residential mortgage loans with a market cap of approximately $588.60 million.
Operations: The company's revenue primarily comes from originating, financing, and selling mortgage loans, generating approximately $1.01 billion.
Insider Ownership: 11%
loanDepot is experiencing significant executive transitions, with founder Anthony Hsieh rejoining as Executive Chairman amid a CEO search. Despite high insider ownership, recent months have seen substantial insider selling. The company is forecast to become profitable within three years and projects earnings growth of 110.16% annually. Revenue growth is expected at 18.4% per year, outpacing the US market average but below the 20% threshold for high growth companies, while maintaining competitive value relative to peers.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include NasdaqCM:ASTH NasdaqGS:AFYA and NYSE:LDI.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。